Dynavax Technologies | الدين



Debt تغيير تاريخ
AbbVie USD 69.89B 2.74B 2025-03
Adma Biologics USD 72.34M 28.99M 2024-12
Amgen USD 56.2B 1.18B 2025-06
AstraZeneca USD 32.84B 1.19B 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Dynavax Technologies USD 260.51M 36.65M 2025-03
Gilead Sciences USD 24.95B 6M 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
Merck USD 34.84B 2.27B 2025-03
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Pfizer USD 60.93B 1.18B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
TG Therapeutics USD 8.98M 235.45M 2025-03
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Dynavax Technologies الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.